nutlin 3 has been researched along with Astrocytoma, Grade IV in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barresi, E; Cosconati, S; Da Pozzo, E; Da Settimo, F; Daniele, S; Di Maro, S; La Motta, C; La Pietra, V; Marinelli, L; Martini, C; Novellino, E; Robello, M; Taliani, S | 1 |
1 other study(ies) available for nutlin 3 and Astrocytoma, Grade IV
Article | Year |
---|---|
Lead Optimization of 2-Phenylindolylglyoxylyldipeptide Murine Double Minute (MDM)2/Translocator Protein (TSPO) Dual Inhibitors for the Treatment of Gliomas.
Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Dipeptides; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Models, Molecular; Molecular Structure; Proto-Oncogene Proteins c-mdm2; Receptors, GABA; Structure-Activity Relationship; Tumor Cells, Cultured | 2016 |